Cannabis Seeds

cannabidiol

U.S.: Corporation Files 2nd Patent Application For CBD/Ibuprofen Pain Combo

CBD/IbuprofenPackage(SteviaCorp)

Stevia Corp., an international farm management company and healthcare company, has announced the filing of a second important provisional patent application with the United States Patent and Trademark Office for pain treatment using a combination of ibuprofen and cannabidiol (CBD).

The provisional patent application closely follows the company's previously announced first provisional patent application for pain management using acetaminophen and CBD. As in the previous application, this patent includes multiple claims including, but not limited to, combinations of cannabinoids including CBD and ibuprofen for the treatment of pain.

The provisional patent application, a legal document which establishes an early priority date for the benefit of claiming "first to file" status against other companies or individuals, "was filed with the assistance of an intellectual property attorney with extensive experience in the healthcare industry," according to a prepared statement from Stevia Corp.

CBD is a cannabinoid present in most varieties of the cannabis sativa and cannabis indica plants. Unlike THC and some of the other molecules found in cannabis, CBD is non-psychoactive.

CBD is also extremely well tolerated at high doses with little or no side effects; it is essentially non-toxic. It catapulted to national prominence after being an important part of Dr. Sanjay Gupta's 2013 CNN documentary, "Weed."

U.S.: Dose of Nature Introduces New CBD Product Line

DoseOfNature

Utah-based Dose of Nature last week launched a state-of-the-art CBD (cannabidiol) product line, applying proprietary technologies to create what it calls "the first nano CBD and water-soluble CBD products in the market."

CBD has been at the forefront of the news lately in its application to treat pediatric epilepsy, autism, cancer, pain, PTSD, brain injuries, anxiety, and various neurological conditions.

Most CBD pastes or oils being used today have a very strong taste and are slowly and poorly absorbed into the body. Dose of Nature says it addresses these issues using its proprietary Hydrosome™ and BioXTrax™ technologies, making water-soluble CBD taste better, more rapidly absorbed, and more bioavailable within minutes of ingestion.

"The Hydrosome™ technology represents a shift in how nutritional supplements, and even pharmaceuticals, can be delivered," said Dr. Rick Potts, president of Dose of Nature. "This integrative approach is far superior to liposomes in terms of unlocking the true potential of natural remedies, optimizing the speed and breadth of nutrient delivery throughout the body."

The new Dose of Nature product line will include:

• Sweet CBD™: this water-soluble form of concentrated CBD is readily absorbed in the stomach, and is created through a multiplex bonding process of highly-refined RedStrap CBD Oil to 100% vegetable glycerin without the need for preservatives, flavors, or emulsifying agents.

U.S.: CannaVest Says Quality, Safety of Its CBD Products Proved By Testing

CannaVest(logo)

CannaVest Corp., a manufacturer and distributor of hemp and cannabidiol (CBD) based products, announced on Thursday that "the results of independent testing have proved the safety and quality of its products."

In December, CannaVest Corp. commenced cooperative efforts with Project CBD to ensure the cannabis/hemp industry and the consuming public is provided with accurate and meaningful information concerning CannaVest Corp.'s CBD offerings. Project CBD is a non-profit educational service dedicated to promoting and publicizing research into the medical utility of cannabidiol (CBD).

CannaVest Corp. initiated its cooperative efforts with Project CBD in response to a special report on the hemp oil industry published by Project CBD titled "Hemp Oil Hustlers" on October 14, 2014 and revised on November 5, 2014.

Project CBD reported that a consumer product, which is labeled as containing hemp oil and which was produced by the company and then sold in 2013 to a distributor, tested positive for hexane and other solvent residues.

Following the publication of the Project CBD report, CannaVest agreed to work with Project CBD to independently test its products. Based on the results of this testing, Project CBD has concluded that CannaVest Corp.'s products are not contaminated with heavy metals or industrial solvent residues in amounts that pose health and safety issues for consumers, according to officially recognized safety standards.

CannaVest and Project CBD have released a joint statement.

U.S.: UltraCBD Releases 2 Ounce 'Hemp Oil' Supplement

UltraCBDBottle400mg

The UltraCBD™ team has released a 2 ounce offering with twice as much hemp extract "to meet the increasing demand for CBD oil."

The 2 oz. 400 mg CBD supplement is available for retail sale in limited quantities and will be available for wholesale orders in the first half of 2015.

"UltraCBD™ takes great pride in using the highest quality extract from industrial hemp ensuring that all products manufactured by the company have the best possible flavoring while maintaining the wellness components of a high-quality CBD supplement," the company claims in a press release.

UltraCBD™ said it launched its first 1 oz. 200 mg CBD supplement "derived from organic, high quality CBD hemp oil" in June 2014. The company said it spent the first half of the year sourcing additional organic CBD oil and conducting research and development, ensuring that all raw materials processed with CO2 extraction are toxin- and heavy metal-free for the American market.

The research & development process included an emphasis on taste testing, according to the company, and the first flavor launched was Natural Spearmint. Additional flavors and product lines launches are planned for 2015.

Brazil: Health Agency To Study CBD-Only Medical Marijuana Law

CBD(Cannabidiol)ForEpilepsy

By Steve Elliott
Hemp News

Brazil will soon study the possibility of legalizing the use of cannabidiol (CBD), a marijuana derivative, to treat people suffering from severe seizures.

The country's Health Surveillance Agency, ANVISA, announced that the "reclassification" of the cannabinoid CBD -- which is illegal in Brazil -- will be discussed starting next month, reports the Associated Press.

The statement came on Friday, one day after about 40 people protested in the capital city of Brasilia to demand the legalization of CBD.

Some Brazilians resort to an underground network of illegal cannabis farmers in Rio de Janeiro that extract the CBD and donate it. That network supplies Margaret de Brito with the oil she gives her five-year-old daughter Sofia, who was born with a genetic mutation that causes seizures.

"They won't even let you pay the shipping," Brito said of the clandestine growers' group.

Her daughter's seizures have decreased dramatically since starting the treatment more than a year ago, and she's been able to stop taking another medication that made her drowsy, Brito said.

The Federal Medical Council, which regulates the medical profession in Brazil, earlier this month authorized neurologists and psychiatrists to prescribe CBD to treat epileptic children and teenagers who don't respond to conventional pharmaceuticals. (You'd think a non-toxic alternative would be the first line of treatment, not the last resort!)

France: THC-Free Marijuana Vape Pen Hitting The Market

KanaVape(ProductShot)

By Steve Elliott
Hemp News

Electronic cigarettes containing extracts of marijuana -- but no psychoactive THC -- are about to hit the market in France any day now. The e-cigs contain cannabinoids, including cannabidiol (CBD), which give relaxing and pain-killing effects, according to the manufacturer.

Three young French entrepreneurs are launching the product, which launches before the end of December, and they claim it will be entirely legal, reports The Local.

"KanaVape brings you many of the benefits of cannabinoids without the psychotic effect of THC," claims the website of the product, due to go on sale this month in France.

"Vape pens" which allow consumers to inhale cannabis or tobacco vapor are increasingly popular in the United States. But they've been rare in Europe until now.

"By using only hemp with 5 percent CBD (Cannabidiol) and no THC, KanaVape provides you with a unique cannabinoids excperience," the company claims. "Cannabidiol is a non-psychotic cannabinoid, it will not make you 'high' but will help you relax." (Note the not-very-subtle substitution of the word "psychotic" for the proper term, "psychoactive," perhaps to demonize THC and make it seem more threatening -- a favorite, albeit quite deceptive, marketing strategy for "CBD-only" purveyors.)

CBD-rich hemp, which is grown legally to make products such as oil, rope, cloth, paper, and fuel, will be used to make the vapor mix.

U.S.: Company Announces 99% Pure CBD For Sale

UsCBDpurFromHempToCrystal

UsCBDpur, an importer of CBD extracted from industrial hemp and containing no THC, on Tuesday announced that they are now offering 100 gram to 1 kilo lots.

UsCBDpur says its cannabidiol is non-synthetic and represents a breakthrough in the clean extraction of CBD from thousand year old cultivars of Asian hemp (old strains bred for high fiber with little regard for any THC content).

"UsCBDpur contains no heavy metals, no THC and no residual cannabinoids/terpenes," states a prepared releasea from the company. It is simply PURE CBD, consistently testing at 99%+ pure!"

The company has what it calls "an affordable 100g entry level" beginning at $12,000. This means they are charging a stiff $120 a gram even at that volume. Rick Simpson Oil (RSO) and Full Extract Cannabis Oil (FECO) often sell for $25 to $40 a gram in the medical marijuana community -- at the single-gram level -- for comparison purposes.

"We decided to provide affordable entry levels for smaller manufacturers and formulation or consultation companies," said company director David Mouser. "If you do the math, it's a 7:1 ratio in costs.

"Everyone will enjoy cutting their CBD oil costs," Mouser said. "And think of the possibilities of pure powder formulations! That's huge, plus it is 100 percent CLEAN."

Michigan: Companies Team Up To Deliver Terpene-Infused Hemp CBD Products

MichiganHempCompany(logo)

Pan's Ink and Michigan Hemp Company on Tuesday announced they have entered into a strategic supply agreement through which Pan's Ink will provide tailored, natural terpene mixtures in bulk to Michigan Hemp Company for use in MHC's hemp CBD products. Pan's Ink will distribute its terpene mixtures to MHC under the Pan's Ink brand, TerpAid™.

Terpenes are an essential part of hemp and cannabis medicine, just as are the cannabinoids, including cannabidiol (CBD). These aromatic compounds work in concert to promote healing and well being through the "entourage effect."

Pan's Ink is known in the legal cannabis, smoking accessories, and aromatherapy industries for its line of terpene customization products. These products are used by customers to target the effects of their legal cannabis or other herbal smoking products in order to provide consistent symptom relief.

Pan's Ink also supplies balanced terpene profiles in bulk form to manufacturers. "We are thrilled to be working with hemp pioneers Joe Brown and the Michigan Hemp Company in this new venture," said Jack Turner, CEO and Founder of Pan's Ink.

"Terpenes are an integral part of cannabis medicine, and our 100 percent natural terpenes are the best in the industry," Turner said. "Teaming up with Michigan Hemp Company will gain Pan's Ink a valuable new relationship and will allow Michigan Hemp Company to augment its already cutting-edge products."

California: Police Raids on Medical Marijuana Gardens Cut Off Treatment For Kids With Epilepsy

CBD-CanBeatDravet

Researchers announce that clinical trials involving anti-convulsive form of marijuana is showing "promise" in children

As promising results from clinical trials are announced in the use of medicinal cannabis (medical marijuana) to treat intractable epilepsy, those lawfully cultivating the plant in California are being raided by local law enforcement. Two gardens destroyed by police in the past two months in Mendocino County and Modesto contained a rare strain of medical marijuana rich in Cannabidiol (or CBD) used by children many of whom do not respond to other drug treatments.

On August 5, unidentified men in camouflage dropped from an unmarked helicopter onto the 120-acre property of Potter Valley resident and cancer survivor Susan Schindler, cutting down her lawfully cultivated medical marijuana plants. In addition to growing for herself, Schindler was cultivating rare strains of medical marijuana rich in CBD, a non-psychotropic constituent of the plant, which were being used orally by children with epilepsy.

Schindler was also cultivating plants rich in THCV, another active constituent (or cannabinoid) that was producing positive results for a patient with Parkinson's disease.

California: Exhale Med Center Offers Highest Tested and Rare CBD Strain

ExhaleMedCenterFlower

Pioneers in cultivating CBD (cannabidiol) genetics for over two years, Exhale Med Center, the #1 rated medical marijuana shop on Yelp, carries one of the rarest strains of CBD-rich cannabis found today, called “CBD Web.” This strain contains 16 percent CBD to 2 percent THC, a ratio high enough to comfort the parents of a sick child suffering from epilepsy, giving them the confidence that the child will not feel high while reaping the medicinal rewards.

CBD Web is a constant at Exhale Med Center, in addition to three variations of CBD-rich strain genetics, CBD edibles, tinctures, creams, Rick Simpson Oils, and many different forms of concentrates. With last year's release of Dr. Sanjay Gupta's CNN Special Weed, a demand has been created for highly concentrated CBD products that will help patients’ symptoms without giving them a psychoactive high.

Known as one of the elite shops in Los Angeles, Exhale Med Center is a Prop D compliant, “Pre-ICO,” medical marijuana pioneer, offering one of the best selections of strain variations in town, in every price range. From high-end indoor sativas and hybrids from the Bay Area and top shelf indicas from SoCal to the outdoor and green house varieties from Northern California’s ‘Emerald Triangle’, Exhale says its range of more than 50 strains offers a quality remedy for most ailments. This December will mark their first year anniversary in their new zone-compliant location at 980 North La Cienega Blvd, Suite 102, Los Angeles, CA 90069.

Wisconsin: Company Readies Hemp-Based Non-Prescription Cannabinoid Medication For Epilepsy

PuraMedBioScience(logo)

PuraMed BioScience, Inc., a company which researches, develops, and markets over-the-counter (OTC) medicinal and healthcare products on Friday announced it is nearing the completion of development of its new non-prescription, hemp-based, homeopathic medication for treatment of epilepsy symptoms including seizures and seizure-related headaches.

Both epilepsy and migraines appear to be triggered by the same cortical spreading depression (CSD) in the brain; the difference is the rate of reaction. This may be why many people who suffer from migraines are prescribed epilepsy medications.

The third most common neurological disorder in the US, epilepsy affects about 2.7 million people, with children and older adults being most susceptible. The condition also causes up to 50,000 sudden deaths each year.

Recent research has shown cannabidiol (CBD), a non-psychoactive cannabinoid found in both hemp and marijuana varieties of cannabis, to be an effective therapy in the treatment of epilepsy symptoms.

"By incorporating standardized hemp oil into our current patented, over-the-counter migraine relief formula, MigraPure, we believe we can offer relief to people who not only suffer with migraines, but also offer relief to people who have seizure-related headaches and other epilepsy-type symptoms," said Russ Mitchell, CEO at PuraMed BioScience.

New York: Governor Asks DOJ To Allow New York To Get Medical Marijuana From Other States

GovernorAndrewCuomoNewYork

Patients, Families, and Advocates Thank Cuomo For Federal Request, But Urge Additional State Action to Save Lives of Critically Ill Patients

Patients Call on Governor to Create State-Based Emergency Access Program

The Cuomo Administration on Friday sent a letter to Deputy Attorney General Cole following up on an earlier letter to U.S. Attorney General Eric Holder, sent on August 13. Both letters asked the federal Department of Justice (DOJ) to extend a narrow, time-limited exception to federal law to allow the importation of certain strains of medical marijuana from other states for use by children in New York with severe forms of epilepsy.

The letters follow the deaths of several children and a sustained campaign by advocates pressuring the Cuomo Administration to create an interim emergency access program for patients who may not survive the 18 months or longer that the governor has said he needs to get the full medical marijuana program up and running. New York passed a medical marijuana bill that Governor Cuomo signed into law in July, but the Administration has said the program won’t be up and running until at least January of 2016.

To establish emergency access for patients in need, medical marijuana can either be produced within New York state, or, with appropriate federal clearances, acquired from a different jurisdiction. The Cuomo Administration’s letters address one of those two options.

South Carolina: Legislative Panel Hears Pleas For Clarity On CBD-Only Medical Marijuana Law

SouthCarolina-JanelRalphAndHarmony

By Steve Elliott
Hemp News

South Carolina lawmakers earlier this year passed one of those "CBD only" bills that allow parents to possess cannabidiol oil, derived from the marijuana plant, for treatment of epileptic seizures. But CBD oil can't be legally made in South Carolina, and it's against federal law to transport it across state lines, so a new Medical Marijuana Study Committee is working out the details of how, exactly, to implement their new law.

That committee met for the first time on Wednesday at the South Carolina Statehouse in Columbia, reports Robert Kittle at WSPA.

CBD oil doesn't have the mind-altering effects of tetrahydrocannabinol (THC), the which gets users high. As written, South Carolina's CBD-only law is just for patients in a clinical trial to treat epilepsy, and it provides no way for them to legally obtain the oil.

Janel Ralph of Myrtle Beach, whose five-year-old daughter Harmony has lissencephaly, which causes seizures, wants the law expanded so that it's not just a clinical trial and not just for epilepsy. She said the law, as written, doesn't really help.

"You're saying you can get it," she said. "You're saying you can give it to your child, and yes we're going to let you do this. But then they're not giving you any way to actually get it legally."

Oklahoma: Governor Announces Support For CBD-Only Medical Marijuana Law

OklahomaGovernorMaryFallin

By Steve Elliott
Hemp News

Oklahoma Governor Mary Fallin on Wednesday announced she wants to work with lawmakers in the next session of the Legislature to legalize cannabidiol oil (CBD) on a limited, medically supervised, trial-only basis.

CBD is a component of the marijuana plant; unlike THC (tetrahydrocannabinol), it does not produce a high. The compound has shown effectiveness in quelling seizures in toddlers with epilepsy and other conditions. The CBD oil isn't smoked; it is not considered a recreational drug.

"I do not support legalizing the recreational use of marijuana," Fallin said, reports Laura Noland at KFOR-TV. "Nor do I support a broadly defined 'medicinal' marijuana use that makes it easy for healthy adults and teenagers to find and buy drugs."

"I do support allowing potentially life-saving medicine to find its way to children in need," the Republican Governor said. "I am very interested in allowing limited, heavily supervised use of non-intoxicating CBD to be delivered on a trial basis to sick children in Oklahoma."

Rep. Jon Echols is preparing to lead a legislative study of allowing medical trials for CBD in treating children affected by severe seizures. Echols said he decided to take on the issue when his niece was told CBD may help with her medical condition.

Washington: Herban Legends Gets A Gift of CBD-Rich Medical Cannabis Tincture

LeBlancCNE(logo)

The Herban Legends Collective scholarship fund announced on Monday that it has received a donation of CBD-­rich tincture from LeBlanc CNE.

Located in White Center, Seattle, Washington, Herban Legends in a prepared statement said it has "a strong commitment to making medical marijuana available to as many patients as possible."

LeBlanc CNE is a grower and broker of medical cannabis with a firm belief that healthcare is a right, not a privilege. To that end, LeBlanc tithes itself and donates medical cannabis to Herban Legends.

LeBlanc's most recent donation was of a tincture, Batch #5, rich in cannabidiol (CBD), the non­-psychoactive compound responsible for many of marijuana's healing effects.

CBD has been used with children suffering from seizures, PTSD, Crohn's disease, chronic pain, and a number of other conditions.

"LeBlanc is proud to support Herban Legend Collective's goal of bringing medical marijuana to an otherwise underserved neighborhood," said Jerry Whiting, founder of LeBlanc CNE. "How can anyone say ‘no' to alleviating the pain and suffering of others?"

According to Whiting, Batch #5 is an alcohol­-based tincture made with cannabis strains like Harlequin and Cannatonic, as opposed to strains of marijuana high in THC favored by recreational users.

Batch #5 was made using 190-proof Everclear. LeBlanc CNE said its whole plant extraction method captured a wide range of cannabinoids and terpenes.

U.S.: Hemp Industries Association Warns About Misbranding CBD Products as Hemp Oil

HempIndustriesAssociation(HIA)

By Steve Elliott
Hemp News

The North American trade group Hemp Industries Association has published its position on what it called the misbranding of cannabidiol (CBD) products as "hemp oil." The new statement from HIA explains the difference between hemp oil and CBD extracts in terms of their respective uses and means of production, and emphasizes the need for accurate language in the marketplace so consumers aren't misled.

"Hemp oil is the common term for hempseed oil, obtained by pressing hemp seeds that contain low levels of CBD, typically less than 25 parts per million (ppm)," the position states. "In contrast, CBD extracts are produced either directly from cannabis flowers that are up to 15 percent CBD (150,000 ppm), or indirectly as a co-product of the flowers and leaves that are mixed in with the stalks during hemp stalk processing for fiber."

The Drug Enforcement Administration attempted to ban important and commerce of hempseed and oil food products in 2001, claiming these products were Schedule I controlled substances. However, HIA successfully sued the CDEA, unequivocally establishing hemp seed, oil, and protein as entirely legal to import, process, sell and consume in the United States.

North Carolina: Legislature Approves CBD Only Bill; Governor To Sign

CBDCannabidiol

By Steve Elliott
Hemp News

The North Carolina Senate unanimously passed a CBD-only medical marijuana bill on Thursday; the bill had already cleared the House 112 to 1 last week, and now awaits the signature of Governor Pat McCrory, who said he plans to sign the bill into law.

"This law will help ease the suffering endured by children from whom no other treatments are effective against seizures," Gov. McCrory said, reports Matthew Burns at WRAL. "I want to congratulate the General Assembly for crafting a bill that not only improves the lives of many North Carolina children and their parents, but also provides common-sense regulation and facilitates clinical research at our major research universities."

"This is helpful to a lot of kids where nothing else seems to help," said state Sen. Tom Apodaca (R-Henderson). "This will put North Carolina on the cutting edge of this type of epilepsy."

The "Hope 4 Haley and Friends" bill, named for six-year-old Haley Ward of Newport, who suffers from daily seizures, allows the medicinal use of cannabidiol (CBD) oil derived from the marijuana plant for the treatment of seizure disorders, particularly those afflicting children, reports Chad Silber at WFMY. Cannabidiol -- unlike THC, the main psychoactive ingredient in cannabis -- doesn't produce a "high."

Florida: Gov. Rick Scott Signs CBD-Only Medical Marijuana Bill Into Law

CharlottesWebStarts

By Steve Elliott
Hemp News

Florida Governor Rick Scott on Monday signed into law a bill allowing the limited use of Charlotte's Web, a specialized strain of marijuana with high cannabidiol (CBD) and almost no tetrahydrocannabinol (THC). The "Charlottes Web" strain, which is used to quell seizures, is non-psychoactive and is named for a Colorado girl whose seizures have been lessened by the strain.

Florida legislators passed the measure earlier this spring with bipartisan support after emotional appeals from parents seeking Charlotte's Web for their kids, reports Bill Cotterell at Reuters.

The reason they asked for, and got a law specifying, the Charlotte's Web strain isn't because it's the only high-CBD strain of cannabis; there are in fact several others. The reason is because Charlotte's Web is the only high-CBD strain mentioned in Dr. Sanjay Gupta's Weed 2 documentary, so that's the only one the Florida of which the parents and legislators in Florida were aware.

Of course, the Stanley brothers in Colorado are more than happy to have laws written in other states that specifies their particular strain, since they stand to make millions of dollars from it.

Wisconsin: Law Allowing Marijuana-Derived CBD Oil For Seizures Remains Unusable

Wisconsin-AmylynneSantiagoVolkerAndNicVolker

By Steve Elliott
Hemp News

Two months after Wisconsin Governor Scott Walker signed into a law a measure allowing the use of cannabidiol (CBD) oil, a marijuana derivative used to quell seizures without getting patients high, nobody has yet been able to access the medicine.

The bad situation is due at least in part because of obstacles foolishly written into the legislation at the last minute, reports Dana Ferguson at the Journal Sentinel.

"It is frustrating," said Amylynne Santiago Volker of the roadblocks between her nine-year-old son, Nicholas, and the experimental treatment. "It's there in paper, but we can't access it."

Unfortunately, Wisconsin's "CBD-only" law appears as useless as most of the rest passed recently by state legislatures who want to be seen as "doing something" in the face of overwhelming popular support for medicinal cannabis, without having the courage to pass an actual medical marijuana law which could help actual patients.

Gov. Walker on Friday told reporters he "wasn't sure" if his administration could do anything to free up access to CBD, but if more could be done through state legislation, Walker claimed he was "committed to working with lawmakers" to do so.

Tennessee: Governor Signs CBD-Only 'Study' Bill Into Law

TennesseeStateFlag

By Steve Elliott
Hemp News

Tennessee Governor Bill Haslam signed a very limited, CBD-only, medical marijuana "study" bill into law last Friday. Sadly, the bill may not ever result in relief for any patients at all.

Senate Bill 2531 creates a four-year study on the medicinal benefits of cannabidiol (CBD), a non-psychoactive component of marijuana, reports the Marijuana Policy Project. The bill specifies that Vanderbilt University will conduct the study, and Tennessee Tech will theoretically grow the cannabis.

As has been the case with similarly weak "CBD-only" legislation passed in other conservative states recently, the many limitations of the bill mean it won't result in relief for patients; Tennessee hasn't become a "medical marijuana state" by any stretch of the imagination.

The law foolishly depends on the cooperation of the Drug Enforcement Administration (DEA) in authorizing the cultivation of marijuana in Tennessee for the study; it's as if those who wrote the bill haven't bothered to inform themselves of the fact that the DEA has never authorized anyone except The University of Mississippi to grow cannabis for the past 50 years.

CBD-only laws leave most potential medical marijuana patients to suffer. CBD has been found effective in quelling seizures, but those treating seizure disorders with medical marijuana are only a small percentage of total patients who could benefit from cannabis.

Syndicate content